Atherosclerosis of carotid arteries and the ACE insertion/deletion polymorphism in subjects with diabetes mellitus type 2

被引:1
|
作者
Diamantopoulos, EJ [1 ]
Andreadis, E [1 ]
Kakou, M [1 ]
Vlachonikolis, I [1 ]
Vassilopoulos, C [1 ]
Giannakopoulos, N [1 ]
Tarassi, K [1 ]
Papasteriades, C [1 ]
Nicolaides, A [1 ]
Raptis, S [1 ]
机构
[1] Univ Athens, Sch Med, Dept Internal Med 4, GR-11527 Athens, Greece
关键词
carotid artery diseases; ultrasonography atherosclerosis; diabetes mellitus; non insulin dependent; genetics; polymorphism genetics; renin angiotensin system;
D O I
暂无
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Background. The aim of the present study was to investigate the association of the angiotensin-converting enzyme (ACE) insertion/deletion (I/D) polymorphism with the ultrasonographically evaluated severity and characteristics of carotid artery atherosclerosis in subjects with diabetes mellitus type 2. Methods. We assessed 184 subjects with diabetes mellitus type 2, 75 mates and 109 females, mean age 61.4+/-7.7 years. All subjects were receiving oral antidiabetic drugs for glycemic control and were free of cardiovascular events. The ACE genotype was analyzed by the polymerase chain reaction (PCR) technique. The ultrasonographic examination of the carotid arteries was performed in both B-mode imaging and Doppler ultrasound. The common carotid artery intima-media thickness was assessed 15-20 mm proximal to the dilatation of the carotid bulb. The atheromatous lesions were classified according to their echogenic characteristics as predominantly echolucent, mixed and predominantly echogenic with under 30, 30-70 and over 70% of the total plaque area echogenicity, respectively. Results. From the total cohort 29 (15.8%) subjects had the 11, 86 (46.7%) the ID and 69 (37.5%) the DD ACE genotypes. The mean carotid artery diameter stenosis was 37+/-17%, 43+/-19% and 40+/-20% (p=NS) and the intima media thickness was 0.94+/-0.24 mm, 0.97+/-0.20 mm and 0.98+/-0.20 min (p=NS) in the 11, ID and DD subgroups, respectively. When the echogenicity was analyzed according to the ACE I/D polymorphism, 12 subjects (41.4%), 13 (44.8%) and 4 (13.8%) with II genotype had predominantly echogenic, mixed and predominantly echolucent lesions, respectively. The ID genotype diabetics were found to have predominantly echogenic plaques in 41 cases (47.7%), mixed in 30 (34.9%) and predominantly echolucent in 15 cases (17.4%). From the 69 DD subjects 19 (27.5%) had predominantly echogenic plaques, 26 (37.7%) had mixed and 24 (34.8%) had predominantly echolucent lesions. Predominantly echolucent plaques were more frequently encountered among diabetics with the DD genotype (p<0.05), even after correction for demographic characteristics, the main risk factors of atherosclerosis and blood glucose control. Conclusions. The ACE genotype seems to be associated with the echogenicity of carotid artery atheromatosis but not with the common carotid artery intima media thickness or the degree of internal carotid artery stenosis in subjects with type 2 diabetes mellitus. The DD genotype may be implicated in the increased cardiovascular risk that characterizes echolucent plaques.
引用
收藏
页码:63 / 69
页数:7
相关论文
共 50 条
  • [21] Polyclonal Serum Free Light Chains Levels Are Associated with Carotid Atherosclerosis in Subjects with Type 2 Diabetes Mellitus
    Aberer, Felix
    Tripolt, Norbert J.
    Eder, Michaela
    Scharnagl, Hubert
    Stojakovic, Tatjana
    Sourij, Harald
    DIABETES, 2017, 66 : A117 - A117
  • [22] Insertion/deletion polymorphism of the ACE gene and adherence to ACE inhibitors
    Schelleman, H
    Klungel, OH
    van Duijn, CM
    Witteman, JCM
    Hofman, A
    de Boer, A
    Stricker, BHC
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 59 (04) : 483 - 485
  • [23] The association of angiotensin converting enzyme (ACE) insertion/deletion (I/D) polymorphism and the presence of diabetic nephropathy (DN) in patients with type 2 diabetes mellitus (DM) according to the duration of diabetes
    Canani, L
    Costa, L
    Gross, J
    DIABETES, 2003, 52 : A479 - A479
  • [24] The ACE insertion/deletion (I/D) polymorphism is associated with an increased risk of secondary failure to sulfonylurea in patients with type 2 diabetes
    Balducci, S
    Iacobellis, G
    Sciullo, E
    Fallucca, F
    DIABETES, 2005, 54 : A284 - A284
  • [25] Prognostic effect of insertion/deletion polymorphism of the ACE gene on renal and cardiovascular clinical outcomes in Chinese patients with type 2 diabetes
    Wang, Y
    Ma, RC
    Ng, MCY
    Chow, CC
    So, WY
    Cockram, CS
    Tong, PCY
    Chan, JCN
    DIABETES CARE, 2005, 28 (02) : 348 - 354
  • [26] Is ACE gene insertion/deletion polimorphism one of the common determinants of the carbohydrate metabolism and hypertension in patients with type 2 diabetes mellitus?
    Wittmann, I
    Molnár, GA
    Wagner, Z
    Vas, T
    Wagner, L
    Melegh, B
    Laczy, B
    Nagy, J
    DIABETOLOGIA, 2003, 46 : A139 - A140
  • [27] An insertion/deletion polymorphism, in the Alpha 2b-adrenoceptor gene is associated with age at onset of type 2 diabetes mellitus
    Papazoglou, D
    Papanas, N
    Papatheodorou, K
    Christakidis, D
    Maltezos, E
    DIABETOLOGIA, 2005, 48 : A129 - A129
  • [28] An insertion/deletion polymorphism in the alpha2B adrenoceptor gene is associated with age at onset of type 2 diabetes mellitus
    Papazoglou, D.
    Papanas, N.
    Papatheodorou, K.
    Kotsiou, S.
    Christakidis, D.
    Maltezos, E.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2006, 114 (08) : 424 - 427
  • [29] Association of angiotensin converting enzyme gene 'insertion/deletion polymorphism with myocardial infarction in patients with type 2 diabetes mellitus
    Seyoum, B
    Berhanu, P
    Estacio, RO
    Raynolds, M
    Esler, A
    Schrier, RW
    DIABETES, 2000, 49 : A147 - +
  • [30] CTTTA Deletion/Insertion polymorphism in 3'-UTR of LEPR gene in type 2 diabetes subjects belonging to Kashmiri population
    Hameed I.
    Masoodi S.R.
    Afroze D.
    Bhat R.A.
    Naykoo N.A.
    Mir S.A.
    Mubarik I.
    Ganai B.A.
    Journal of Diabetes & Metabolic Disorders, 13 (1):